Jenburkt Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Jenburkt Pharma	Prevest Denpro	Kilitch Drugs(India)
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	0.29 %	n/a	n/a
Financials
5 yr Average ROE	18.49 %	19.0 %	7.31 %
5yr average Equity Multiplier	1.17	1.07	1.48
5yr Average Asset Turnover Ratio	0.88	0.6	0.56
5yr Avg Net Profit Margin	18.1 %	29.64 %	8.44 %
Price to Book	2.43	3.74	1.8
P/E	13.71	21.81	18.3
5yr Avg Cash Conversion Cycle	-32.02 Days	42.6 Days	14.76 Days
Inventory Days	24.72 Days	36.0 Days	14.42 Days
Days Receivable	48.38 Days	44.41 Days	136.16 Days
Days Payable	82.6 Days	39.32 Days	212.73 Days
5yr Average Interest Coverage Ratio	87.2	99.71	6.02
5yr Avg ROCE	24.44 %	25.39 %	11.26 %
5yr Avg Operating Profit Margin	22.46 %	36.91 %	12.28 %
5 yr average Debt to Equity	0.02	0.0	0.17
5yr CAGR Net Profit	14.21 %	2.94 %	48.72 %
5yr Average Return on Assets	15.8 %	17.71 %	4.99 %
Shareholdings
Promoter Holding	46.65 %	73.6 %	63.77 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.68 %	0.0	-4.48 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Jenburkt Pharma	Prevest Denpro	Kilitch Drugs(India)
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Dermatology 0 Dental Materials 0	Product Wise Break-Up Pharmaceutical 0 Dental Materials 100.0 Dermatology 0	Product Wise Break-Up Pharmaceutical 0 Dental Materials 0 Dermatology 0 Others 100
Location Wise Break-Up	Location Wise Break-Up India 87.23 Rest of the World 12.56 Lebanon 0 Morocco 0 Saudi Arabia 0 Indonesia 0 UK 0 South America 0 Oceania 0 Africa 0 Asia 0 North America 0 Europe 0 Others 0.21	Location Wise Break-Up India 38.97 UK 0 Rest of the World 0 Lebanon 0 Morocco 0 Saudi Arabia 0 Africa 0 South America 0 Oceania 0 Europe 0 Indonesia 0 North America 0 Asia 0 Others 61.03	Location Wise Break-Up India 43.49 UK 0 Rest of the World 55.97 Lebanon 0 Morocco 0 Saudi Arabia 0 Africa 0 South America 0 Oceania 0 Europe 0 Indonesia 0 North America 0 Asia 0 Others 0.54